Omega Healthcare Investors Inc

Latest Results (19.12.2024):

Revenue and Earnings

In the third quarter of 2024, Omega Healthcare Investors Inc. reported a significant increase in revenue, driven by new investments and strategic asset sales. The company's earnings before interest, taxes, depreciation, amortization, and rent (EBITDAR) showed a robust performance, reflecting the strength of its operator partnerships and efficient cost management.

Dividend Declaration

Omega Healthcare Investors Inc. declared a quarterly cash dividend of $0.67 per share for the third quarter of 2024. This dividend is scheduled to be paid on November 15, 2024, to shareholders of record as of November 4, 2024, demonstrating the company's commitment to returning value to its investors.

Balance Sheet and Liquidity

As of September 30, 2024, Omega Healthcare Investors Inc. maintained a strong balance sheet with $4.9 billion in outstanding indebtedness and a weighted-average annual interest rate of 4.6%. The company also reported $342.4 million in cash and cash equivalents, along with $1.45 billion of undrawn capacity under its unsecured revolving credit facility, ensuring ample liquidity for future opportunities.

Adjusted FFO Guidance

Omega Healthcare Investors Inc. increased its 2024 Adjusted Funds From Operations (AFFO) guidance to a range of $2.84 to $2.86 per diluted share, up from the previous range of $2.78 to $2.84. This revision reflects the impact of $834 million in new investments and strategic asset sales, highlighting the company's positive outlook for the remainder of the year.

Stock Purchase and ATM Program

During the third quarter of 2024, Omega Healthcare Investors Inc. successfully executed its Common Stock Purchase Plan and ATM Program, raising $90.469 million through the issuance of 2,575 thousand shares at an average price of $35.13 per share. This capital raising effort supports the company's growth initiatives and strengthens its financial position.